Lymphomas and oncolytic virus therapy

被引:4
|
作者
Alain, T
Thirukkumaran, C
Morris, DG
Urbanski, SJ
Janowska-Wieczorek, A
Lee, PWK
Kossakowska, AE
机构
[1] Univ Calgary, Canc Biol Res Grp, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Dept Pathol, Calgary, AB T2N 1N4, Canada
[3] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 1N4, Canada
[4] Calgary Lab Serv, Calgary, AB, Canada
[5] Tom Baker Canc Clin, Calgary, AB, Canada
[6] Univ Alberta, Dept Med, Edmonton, AB T6G 2M7, Canada
[7] Canadian Blood Serv, Edmonton, AB, Canada
来源
CLINICAL LYMPHOMA | 2003年 / 4卷 / 02期
关键词
autotransplant; cytotoxicity; G207; herpes virus; ONYX-015;
D O I
10.3816/CLM.2003.n.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There are several well-documented cases in medical literature of the remission of leukemias and malignant lymphomas following natural human viral infections. In the hope of being able to reproduce these spontaneous tumor regressions, investigators have studied various viruses with distinct oncolytic properties. The first attempts to treat patients with oncolytic viruses took place > 80 years ago; however, it achieved little success. With modern technologies and current knowledge of viruses and cancer, there is an expectation for the discovery of efficient oncolytic viral therapies. This article will review the current knowledge of oncolytic viruses in relation to the treatment of lymphoma.
引用
收藏
页码:104 / 111
页数:8
相关论文
共 50 条
  • [31] Measles virus-mediated oncolytic treatment of cutaneous T cell lymphomas
    Oberholzer, PA
    Heinzerling, L
    Kuendig, TM
    Kuenzi, V
    Naim, H
    Burg, G
    Dummer, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A56 - A56
  • [32] Multicellular tumor spheroids in gene therapy and oncolytic virus therapy
    Lamfers, ML
    Hemminki, A
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (04) : 403 - 411
  • [33] IN VITRO INVESTIGATION OF VARIZELLA ZOSTER VIRUS AS AN ONCOLYTIC VIRUS IN GLIOBLASTOMA THERAPY
    Thon, N.
    Leske, H.
    Schichor, C.
    Tonn, J.
    Goldbrunner, R.
    Baiker, A.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1066 - 1067
  • [34] Integrating innate and adaptive immunity in oncolytic virus therapy
    DePeaux, Kristin
    Delgoffe, Greg M.
    TRENDS IN CANCER, 2024, 10 (02) : 135 - 146
  • [35] Modulation of tumor microenvironment enhances oncolytic virus therapy
    Kurozumi, Kazuhiko
    Hardcastle, Jayson
    Yang, Ming
    Christoforidis, Gregory
    Carson, William
    Chiocca, Antonio
    Kaur, Balveen
    JOURNAL OF NEURO-ONCOLOGY, 2008, 87 (02) : 209 - 210
  • [36] Oncolytic Vaccinia Virus Therapy of Salivary Gland Carcinoma
    Chernichenko, Natalya
    Linkov, Gary
    Li, Pingdong
    Bakst, Richard L.
    Chen, Chun-Hao
    He, Shuangba
    Yu, Yong A.
    Chen, Nanhai G.
    Szalay, Aladar A.
    Fong, Yuman
    Wong, Richard J.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2013, 139 (02) : 173 - 182
  • [37] Combining oncolytic virus and radiation therapy for cancer management
    Jayalie, Vito Filbert
    Sekarutami, Sri Mutya
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [38] Herpes simplex virus oncolytic vaccine therapy in melanoma
    Sivendran, Shanthi
    Pan, Michael
    Kaufman, Howard L.
    Saenger, Yvonne
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (07) : 1145 - 1153
  • [39] Engineering and combining oncolytic measles virus for cancer therapy
    Leber, Mathias F.
    Neault, Serge
    Jirovec, Elise
    Barkley, Russell
    Said, Aida
    Bell, John C.
    Ungerechts, Guy
    CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 56 : 39 - 48
  • [40] Fighting Cancer with Viruses: Oncolytic Virus Therapy in China
    Wei, Ding
    Xu, Jing
    Liu, Xin-Yuan
    Chen, Zhi-Nan
    Bian, Huijie
    HUMAN GENE THERAPY, 2018, 29 (02) : 151 - 159